In the beginning, there was SSgA’s factor soup

On October 16, the investment committee of State Street Global Advisors (SSgA), the Boston-based asset manager with $770 billion under management, will decide whether to implement an investment model derived from genetic programming exercises for its $380 million SSgA Emerging Markets equity fund. The fund is rated four out of five stars by closely followed US-based investment fund research company Morningstar.

There is a strong argument for using the new model, says Anthony Foley, head of

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: